Leo Ehrlich
Net worth: 4 334 $ as of 2026-02-27
Net worth: 4 334 $ as of 2026-02-27
Mr. Leo Ehrlich, CPA, is a Chairman, CEO, Chief Financial Officer & Secretary at Innovation Pharmaceuticals, Inc. Mr. Ehrlich was previously employed as a Chief Financial Officer by Cellceutix Pharma, Inc., a Chief Financial Officer by NanoViricides, Inc. /Old/, a President, CEO, COO, CFO, Secretary & Director by StatSure Diagnostic Systems, Inc., and a Chief Financial Officer & Director by NanoViricides, Inc. He received his undergraduate degree from Baruch College.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-09-27 | 4,333,936 ( -.--% ) | 4 334 $ | 2026-02-27 |
| Companies | Position | Start |
|---|---|---|
| INNOVATION PHARMACEUTICALS INC. | Chief Executive Officer | 2010-11-04 |
| Companies | Position | End |
|---|---|---|
Cellceutix Pharma, Inc.
Cellceutix Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as an early stage developmental biopharmaceutical company | Director of Finance/CFO | 2007-12-05 |
| NANOVIRICIDES, INC. | Director of Finance/CFO | 2007-05-15 |
NanoViricides, Inc. /Old/
NanoViricides, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Director of Finance/CFO | 2007-04-30 |
| STATSURE DIAGNOSTIC SYSTEMS, INC. | Chief Executive Officer | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 6 |
|---|---|
StatSure Diagnostic Systems, Inc.
StatSure Diagnostic Systems, Inc. Medical SpecialtiesHealth Technology Develops and manufactures medical specimen collection devices for the rapid tests of infectious diseases | Health Technology |
Baruch College
Baruch College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NanoViricides, Inc. /Old/
NanoViricides, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
NanoViricides, Inc.
NanoViricides, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes anti-viral therapeutics | Health Technology |
Cellceutix Pharma, Inc.
Cellceutix Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as an early stage developmental biopharmaceutical company | Health Technology |
Innovation Pharmaceuticals, Inc.
Innovation Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company, which focuses on discovering small molecule drugs for hard to treat diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions